Tamibarotene: a new hope for therapeutic efficacy in hepatocellular carcinoma patients Junliang FuJi-Yuan ZhangFu-Sheng Wang Editorial 28 December 2013 Pages: 1 - 3
The challenges of novel contrast agents for the imaging diagnosis of hepatocellular carcinoma Carmen AyusoJordi Bruix Editorial 28 December 2013 Pages: 4 - 6
Balance lost: T cell immunity in progressive HBV infection Bertram BengschRobert Thimme Editorial 09 January 2014 Pages: 7 - 9
Speckle tracking echocardiography in cirrhosis: is it ready for prime time? Florence Wong Editorial 09 January 2014 Pages: 10 - 13
Long-term culture of primary hepatocytes: new matrices and microfluidic devices Britta BurkhardtJuan José Martinez-SanchezAndreas K. Nüssler Review Article 21 November 2013 Pages: 14 - 22
Advancements in in vitro hepatic models: application for drug screening and therapeutics Apeksha DamaniaEra JainAshok Kumar Review Article 05 December 2013 Pages: 23 - 38
Loss of HBsAg and antiviral treatment: from basics to clinical significance Yuecheng YuJinlin HouLanjuan Li Review Article 03 January 2014 Pages: 39 - 54
The co-inhibitory pathway and cellular immune imbalance in the progress of HBV infection Jie ChenLanlan WangYun Liao Original Article 27 August 2013 Pages: 55 - 63
Nucleoside analogs prevent disease progression in HBV-related acute-on-chronic liver failure: validation of the TPPM model Junshuai WangKe MaQin Ning Original Article 28 November 2013 Pages: 64 - 71
Two-year results of a randomized, phase III comparative trial of telbivudine versus lamivudine in Chinese patients Ji-Dong JiaJin-Lin HouAldo Trylesinski Original Article 28 November 2013 Pages: 72 - 82
Predictive value of FIB-4 and APRI versus METAVIR on sustained virologic response in genotype 1 hepatitis C patients Peter FerenciRodrigo AiresAndrzej Horban Original Article 22 November 2013 Pages: 83 - 93
An open-label phase I/II study of tamibarotene in patients with advanced hepatocellular carcinoma Fumihiko KanaiShuntaro ObiMasao Omata Original Article 25 July 2013 Pages: 94 - 103
Hepatocellular carcinoma 20 mm or smaller in cirrhosis patients: early magnetic resonance enhancement by gadoxetic acid compared with gadopentetate dimeglumine Cai-Zhong ChenSheng-Xiang RaoMeng-Su Zeng Original Article 17 August 2013 Pages: 104 - 111
Hepatitis C viral load predicts tumor recurrence after curative resection of hepatocellular carcinoma regardless of the genotype of hepatitis C virus Junichi ShindohKiyoshi HasegawaNorihiro Kokudo Original Article 28 December 2013 Pages: 112 - 120
Non-alcoholic fatty liver disease in a young multiracial Asian population: a worrying ethnic predilection in Malay and Indian males Wah-Kheong ChanNorhaniza BaharKhean-Lee Goh Original Article 03 January 2014 Pages: 121 - 127
Acute liver failure after amanitin poisoning: a porcine model to detect prognostic markers for liver regeneration Karolin ThielMartin SchenkChristian Thiel Original Article 04 December 2013 Pages: 128 - 136
Everolimus-based immunosuppression in liver transplant recipients: a single-centre experience Εvangelos CholongitasIoannis GoulisThemistoklis Vasiliadis Original Article 28 December 2013 Pages: 137 - 145
Left atrial function is impaired in cirrhosis: a speckle tracking echocardiographic study Francisco SampaioJoana PimentaVasco Gama Original Article 27 August 2013 Pages: 146 - 153
